BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy
Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)
Loading
Please wait while we load your information from QuoteMedia.